Your browser has either disabled or does not support javascript. Javascript is required for full website experience.
Aduro BioTech Inc.
ADRO
$
14.6
0.034%
Wed December 9th, 2020
21:45
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
Press Releases
North America Cancer Vaccines Market Report 2020-2027 Featuring Leading Players - AstraZeneca, GSK, Aduro Biotech, Pfizer, Sanofi, Bristol-Myers Squibb, Moderna, OncBioMune, MaxiVAX, Nouscom
PR Newswire
Tue December 1st, 2020
17:00
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
Rating
Analysis
Aduro Biotech (KDNY) Upgraded to Buy: What Does It Mean for the Stock?
Zacks
Fri November 6th, 2020
01:20
Analysis
Aduro Biotech (KDNY) Reports Q3 Loss, Tops Revenue Estimates
Zacks
Thu October 29th, 2020
16:35
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
Earnings
Analysis
Aduro Biotech (KDNY) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
Zacks
Fri October 16th, 2020
16:00
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
Rating
Analysis
Aduro Biotech (KDNY) Upgraded to Buy: Here's What You Should Know
Zacks
Tue October 13th, 2020
16:00
Analysis
Here's Why Momentum Investors Will Love Aduro Biotech (KDNY)
Zacks
Mon August 17th, 2020
13:15
Press Releases
Analysis
Global Cancer Immunotherapy Market Analysis & Forecast to 2023: Profiles of Key Players Aduro BioTech, Amgen, Advaxis, Biogen Idec, GlobeImmune and More
PR Newswire
Mon August 3rd, 2020
23:15
Analysis
Aduro Biotech (ADRO) Reports Q2 Loss, Tops Revenue Estimates
Zacks
Thu July 30th, 2020
16:33
Earnings
Analysis
Aduro Biotech (ADRO) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
Zacks
Tue June 2nd, 2020
11:30
Press Releases
Aduro Biotech and Chinook Therapeutics Announce Definitive Merger Agreement
Benzinga
Mon May 25th, 2020
16:00
Rating
Analysis
Aduro Biotech (ADRO) Upgraded to Buy: What Does It Mean for the Stock?
Zacks
+ 3 more
15:30
Analysis
Is Aduro Biotech (ADRO) Outperforming Other Medical Stocks This Year?
Zacks
